Core-shell magnetic composite particle coated with phosphorylcholine-containing polymer and preparation method thereof
A technology of magnetic composite particles and phosphorylcholine, which is applied to medical preparations containing active ingredients, wave energy or particle radiation treatment materials, medical preparations with non-active ingredients, etc., to achieve good biocompatibility and clear preparation methods Simple and efficient, good in vivo degradability effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] Example 1: Core-shell Fe with a shell thickness of about 150 nm, using BACy as a cross-linking agent and a cross-linking degree of 15% 3 O 4 Preparation of @PMPC Composite Particles
[0032] 1. Preparation of Citric Acid Stabilized Magnetic Clusters
[0033] 4.32g of ferric chloride hexahydrate (FeCl 3 6H2O), 4.8g sodium acetate (NaOAc), 1g sodium citrate were ultrasonically dissolved in 80ml ethylene glycol, then added to a 150ml three-necked flask, heated to 165°C, mechanically stirred, and incubated for 1.5h. The liquid was quickly transferred to a 100ml high-pressure reaction kettle containing a polytetrafluoroethylene lining, and then the reaction kettle was placed in an oven at 200°C for 22 hours of reaction, taken out, and cooled to room temperature with tap water. The product is separated by magnetic separation, and the unreacted reactants are removed by alternately washing with absolute ethanol and distilled water, and finally the product is freeze-dried for...
Embodiment 2
[0036] Example 2: Core-shell Fe with a shell thickness of about 100 nm, using BACy as a cross-linking agent and a cross-linking degree of 8% 3 O 4 Preparation of @PMPC composite particles 1. The preparation of citric acid-stabilized magnetic clusters is the same as described in Example 1-1;
[0037] 2. Fe 3 O 4 The @PMPC composite particles were prepared as described in Examples 1-2. The difference is that the amount of cross-linking agent BACy is 8.8 mg.
Embodiment 3
[0038] Example 3: Core-shell Fe with a shell thickness of about 50 nm, using BACy as a cross-linking agent and a cross-linking degree of 8% 3 O 4 Preparation of @PMPC Particles
[0039] 1. The preparation of citric acid-stabilized magnetic clusters is the same as described in Example 1-1;
[0040] 2. Fe 3 O 4 The @PMPC composite particles were prepared as described in Examples 1-2. The difference is that the dosages of 2-methacryloyloxyethylphosphorylcholine, BACy, and 2,2-azobisisobutyronitrile are 50 mg, 3.5 mg, and 0.7 mg, respectively.
PUM
Property | Measurement | Unit |
---|---|---|
thickness | aaaaa | aaaaa |
thickness | aaaaa | aaaaa |
thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com